NutriBand (NTRB) Accounts Payables (2016 - 2026)
NutriBand (NTRB) posted Accounts Payables of $639192.0 for Q2 2026, up 27.16% sequentially from $502654.0 in Q1 2026, and down 11.43% YoY from $721671.0 in Q2 2025.
NutriBand (NTRB) Accounts Payables (2016 - 2026) Analysis & Trends
NutriBand has reported Accounts Payables for 11 years, with the latest figure at $639192.0 in Q2 2026.
- Quarterly Accounts Payables fell 11.43% year-over-year to $639192.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $639192.0 (down 11.43% YoY) and the FY2026 annual result came in at $502654.0, down 28.07% from the prior year.
- Accounts Payables improved to $639192.0 in Q2 2026 per NTRB's latest filing, from $502654.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $1.4 million in Q3 2025 and troughed at $387862.0 in Q4 2023.
- A 5-year average of $677807.3 and a median of $630026.5 in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables sank 38.74% in 2022, then soared 130.02% in 2024.
- Over 5 years, Accounts Payables stood at $535841.0 in 2022, then retreated by 27.62% to $387862.0 in 2023, then jumped by 130.02% to $892154.0 in 2024, then plunged by 32.16% to $605209.0 in 2025, then gained by 5.62% to $639192.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $639192.0, $502654.0, and $605209.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 639,192.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 639,192.00 |
| Jan 31, 2026 | 502,654.00 |
| Oct 31, 2025 | 605,209.00 |
| Jul 31, 2025 | 1.39 Mn |
| Apr 30, 2025 | 721,671.00 |
| Jan 31, 2025 | 698,821.00 |
| Oct 31, 2024 | 892,154.00 |
| Jul 31, 2024 | 778,827.00 |
| Apr 30, 2024 | 994,106.00 |
| Jan 31, 2024 | 680,132.00 |
| Oct 31, 2023 | 387,862.00 |
| Jul 31, 2023 | 496,778.00 |
| Apr 30, 2023 | 543,753.00 |
| Jan 31, 2023 | 534,679.00 |
| Oct 31, 2022 | 535,841.00 |
| Jul 31, 2022 | 620,861.00 |
| Apr 30, 2022 | 535,440.00 |
| Jan 31, 2022 | 639,539.00 |
| Oct 31, 2021 | 644,543.00 |
| Jul 31, 2021 | 975,596.00 |